FR04C0024I2 - - Google Patents

Info

Publication number: FR04C0024I2
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR04C0024C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott Healthcare Products BV

Original Assignee

Solvay Pharmaceuticals BV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-11-30

Filing date

2004-10-22

Publication date

2010-12-31

2004-03-12 Publication of FR04C0024I1 publication Critical patent/FR04C0024I1/fr

2004-10-22 Application filed by Solvay Pharmaceuticals BV filed Critical Solvay Pharmaceuticals BV

2010-12-31 Application granted granted Critical

2010-12-31 Publication of FR04C0024I2 publication Critical patent/FR04C0024I2/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FR04C0024C 1992-11-30 2004-10-22 Active FR04C0024I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9203594A SE9203594D0 (en)	1992-11-30	1992-11-30	DISPERSA SYSTEM MEDICINAL PRODUCT
PCT/SE1993/001029 WO1994012153A1 (en)	1992-11-30	1993-11-29	A pharmaceutical formulation

Publications (2)

Publication Number	Publication Date
FR04C0024I1 FR04C0024I1 (en)	2004-03-12
FR04C0024I2 true FR04C0024I2 (en)	2010-12-31

Family

ID=20387973

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR04C0024C Active FR04C0024I2 (en)	1992-11-30	2004-10-22

Country Status (15)

Country	Link
US (1)	US5635213A (en)
EP (1)	EP0670713B3 (en)
JP (1)	JP3661703B2 (en)
AT (1)	ATE184191T3 (en)
AU (1)	AU688290B2 (en)
CA (1)	CA2150464C (en)
DE (2)	DE122005000021I1 (en)
DK (1)	DK0670713T3 (en)
ES (1)	ES2137350T7 (en)
FR (1)	FR04C0024I2 (en)
GR (1)	GR3031988T3 (en)
NL (1)	NL300169I1 (en)
NZ (1)	NZ258276A (en)
SE (1)	SE9203594D0 (en)
WO (1)	WO1994012153A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7919109B2 (en)	1999-02-08	2011-04-05	Intarcia Therapeutics, Inc.	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) *	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
JP4653893B2 (en) *	2000-01-27	2011-03-16	純一須藤	Bilayer type transdermal preparation
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20050119249A1 (en) *	2003-12-02	2005-06-02	Erik Buntinx	Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7884096B2 (en) *	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
CA2547639A1 (en) *	2003-12-02	2005-06-16	B&B Beheer Nv	Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
US7855195B2 (en) *	2003-12-02	2010-12-21	Pharmaneuroboost N.V.	Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (en)	2006-05-30	2010-11-04	Intarcia Therapeutics Inc	SECONDARY FLOW MODULATOR WITH AN INTERNAL CHANNEL FOR AN OSMOTIC OUTPUT SYSTEM
MX2008015339A (en) *	2006-05-31	2008-12-16	Solvay Pharm Gmbh	Long term 24 hour intestinal administration of levodopa/carbidopa.
EP2359808B1 (en)	2006-08-09	2013-05-22	Intarcia Therapeutics, Inc	Osmotic delivery systems and piston assemblies
AU2008244523B2 (en)	2007-04-23	2012-02-16	Intarcia Therapeutics, Inc.	Suspension formulations of insulinotropic peptides and uses thereof
EP2170283B1 (en)	2007-06-22	2019-01-09	Board of Regents, The University of Texas System	Formation of stable submicron peptide or protein particles by thin film freezing
DK2240155T3 (en)	2008-02-13	2012-09-17	Intarcia Therapeutics Inc	Devices, formulations and methods for the delivery of several beneficial agents
US8779094B2 (en)	2008-11-16	2014-07-15	Board Of Regents, The University Of Texas System	Low viscosity highly concentrated suspensions
LT2462246T (en)	2009-09-28	2017-11-27	Intarcia Therapeutics, Inc	IMMEDIATE IMPLEMENTATION AND / OR TERMINATION OF IMMEDIATE STATIONARY SUPPLY
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP2653179B1 (en)	2012-04-17	2019-07-10	Micrel Medical Devices S.A.	System for calculating and administering a drug to a patient with Parkinson's disease
RS65337B1 (en)	2014-09-04	2024-04-30	Lobsor Pharmaceuticals Ab	Pharmaceutical gel compositions comprising levodopa, carbidopa and entacapone
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102537018B1 (en)	2014-10-21	2023-05-30	애브비 인코포레이티드	Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
MA41377A (en)	2015-01-20	2017-11-28	Abbvie Inc	LEVODOPA AND CARBIDONA INTESTINAL GEL AND PROCEDURES FOR USE
BR112017023674A2 (en)	2015-05-06	2018-07-17	Synagile Corporation	pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
US10555922B2 (en)	2015-09-04	2020-02-11	Lobsor Pharmaceuticals Aktiebolag	Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor
EP3458084B1 (en)	2016-05-16	2020-04-01	Intarcia Therapeutics, Inc	Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
US20180021280A1 (en) *	2016-07-20	2018-01-25	Abbvie Inc.	Levodopa and Carbidopa Intestinal Gel and Methods of Use
KR20190104039A (en)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Methods Including Continuous Administration of GLP-1 Receptor Agonists and Co-administration of Drugs
MA52122A (en)	2018-03-02	2021-04-28	Chiesi Farm Spa	PHARMACEUTICAL FORMULATION FOR INTRADUODENAL ADMINISTRATION CONSISTING OF MELVODOPA AND CARBIDOPA
CN112261940B (en)	2018-03-23	2024-02-27	劳波索尔制药有限公司	Continuous administration of pharmaceutical compositions for the treatment of neurodegenerative diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5831210B2 (en) *	1973-04-09	1983-07-05	武田薬品工業株式会社	antennae
DE2714065A1 (en) *	1977-03-30	1978-10-12	Boehringer Mannheim Gmbh	INSTILLATION PREPARATION
US4356824A (en) *	1980-07-30	1982-11-02	Vazquez Richard M	Multiple lumen gastrostomy tube
CH652025A5 (en) *	1981-09-14	1985-10-31	Hoffmann La Roche	Pharmaceutical preparation.
US4916151A (en) *	1985-12-05	1990-04-10	Merrell Dow Pharmaceuticals Inc.	Method of treating parkinson's syndrome
SE457326B (en) *	1986-02-14	1988-12-19	Lejus Medical Ab	PROCEDURES FOR PREPARING A QUICK SUBSTANTIAL CANDLES CONTAINING BLA MICROCRISTALLIN CELLULOSA
EP0252290B1 (en) *	1986-06-10	1992-06-03	CHIESI FARMACEUTICI S.p.A.	Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
US4832957A (en) *	1987-12-11	1989-05-23	Merck & Co., Inc.	Controlled release combination of carbidopa/levodopa
GB8720600D0 (en) *	1987-09-02	1987-10-07	Saad Al Damluji	Pharmaceutical compositions
US4863962A (en) *	1988-03-02	1989-09-05	Fidia-Georgetown Institute For The Neurosciences	D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease
US5326572A (en) *	1989-03-23	1994-07-05	Fmc Corporation	Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
US5266332A (en) *	1991-12-06	1993-11-30	Alza Corporation	Method for administering anti-Parkinson drug
US5354885A (en) *	1992-12-24	1994-10-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Process for preparing ethyl ester of L-DOPA

1992
- 1992-11-30 SE SE9203594A patent/SE9203594D0/en unknown
1993
- 1993-11-29 EP EP94901148.0A patent/EP0670713B3/en not_active Expired - Lifetime
- 1993-11-29 ES ES94901148.0T patent/ES2137350T7/en active Active
- 1993-11-29 AT AT94901148T patent/ATE184191T3/en unknown
- 1993-11-29 US US08/446,799 patent/US5635213A/en not_active Expired - Lifetime
- 1993-11-29 DK DK94901148T patent/DK0670713T3/en active
- 1993-11-29 DE DE200512000021 patent/DE122005000021I1/en active Pending
- 1993-11-29 JP JP51306094A patent/JP3661703B2/en not_active Expired - Lifetime
- 1993-11-29 CA CA002150464A patent/CA2150464C/en not_active Expired - Lifetime
- 1993-11-29 DE DE69326350.4T patent/DE69326350T3/en not_active Expired - Lifetime
- 1993-11-29 WO PCT/SE1993/001029 patent/WO1994012153A1/en active IP Right Grant
- 1993-11-29 AU AU55836/94A patent/AU688290B2/en not_active Expired
- 1993-11-29 NZ NZ258276A patent/NZ258276A/en not_active IP Right Cessation
1999
- 1999-11-30 GR GR990403081T patent/GR3031988T3/en unknown
2004
- 2004-10-22 FR FR04C0024C patent/FR04C0024I2/fr active Active
2005
- 2005-01-03 NL NL300169C patent/NL300169I1/en unknown

Also Published As

Publication number	Publication date
DK0670713T3 (en)	2000-03-20
FR04C0024I1 (en)	2004-03-12
DE122005000021I1 (en)	2006-02-23
US5635213A (en)	1997-06-03
ATE184191T3 (en)	1999-09-15
CA2150464C (en)	2002-02-05
WO1994012153A1 (en)	1994-06-09
JP3661703B2 (en)	2005-06-22
JPH08504764A (en)	1996-05-21
DE69326350T3 (en)	2018-01-11
EP0670713B3 (en)	2016-10-05
GR3031988T3 (en)	2000-03-31
DE69326350D1 (en)	1999-10-14
CA2150464A1 (en)	1994-06-09
ES2137350T7 (en)	2017-11-13
AU5583694A (en)	1994-06-22
SE9203594D0 (en)	1992-11-30
AU688290B2 (en)	1998-03-12
ES2137350T3 (en)	1999-12-16
NL300169I1 (en)	2005-03-01
EP0670713A1 (en)	1995-09-13
NZ258276A (en)	1996-09-25
EP0670713B1 (en)	1999-09-08
DE69326350T2 (en)	2000-01-27

Publication	Publication Date	Title
DK0634000T3 (en)	1997-02-24
NO942911D0 (en)	1994-08-05
FR04C0024I2 (en)	2010-12-31
DK0551248T3 (en)	1997-02-17
DK0630289T3 (en)	1997-02-24
DK145092D0 (en)	1992-12-03
DK0599160T3 (en)	1997-02-24
TW246753B (en)	1995-05-01
DK0644844T3 (en)	1997-01-20
DK0657012T3 (en)	1997-03-10
DK0553681T3 (en)	1997-02-10
DK0576346T3 (en)	1997-03-10
DK0581129T3 (en)	1997-03-17
DK0571874T3 (en)	1997-03-13
DK0599441T3 (en)	1997-01-20
DK0576097T3 (en)	1997-02-24
DK0590732T3 (en)	1997-05-12
FR2687647B1 (en)	1995-05-05
DE9207553U1 (en)	1992-10-01
DE9209779U1 (en)	1992-09-17
FR2688884B1 (en)	1995-01-27
DK100792D0 (en)	1992-08-12
DK117092D0 (en)	1992-09-22
DK137892D0 (en)	1992-11-13
IN180673B (en)	1998-02-28